部分
钥匙(锁)
尿素
计算机科学
算法
化学
流量(数学)
人工智能
机器学习
有机化学
数学
几何学
计算机安全
作者
Haripriya Thalla,Varshini Jayaraman,Mahesh Kumar Uppada,Vishnuvardhan Reddy Eda,S. Sen,Rakeshwar Bandichhor,Srinivas Oruganti
标识
DOI:10.1021/acs.oprd.3c00489
摘要
Unsymmetrical urea is a ubiquitous moiety in pharmaceuticals, providing a linkage between pharmacophores. The assembly of an unsymmetrical urea bridge in various therapeutic agents can be accomplished through several approaches. Conventional methods involving hazardous compounds such as phosgene and isolated isocyanates pose safety concerns; a safe surrogate of phosgene, namely CDI, is popularly employed for the construction of both symmetrical and unsymmetrical urea. While the use of CDI for the small-scale synthesis of NCEs is a popular strategy, translation of the same chemistry to the large-scale manufacture of unsymmetrical urea containing APIs often encounters certain challenges such as symmetrical urea formation, solubility, and purification issues. Consequently, alternate approaches involving the intermediacy of a stable alkyl/aryl carbamate are typically adopted in manufacturing scenarios. Herein, we describe an effective supervised ML approach involving minimal data sets of flow chemistry parameters to accelerate the process optimization of CDI-based unsymmetrical urea construction for the anticancer drug Larotrectinib. A series of multi-output regression and ensemble models were evaluated to identify the best one that can be employed for rapid and effective reaction optimization. Using this approach, we were able to arrive at the optimal experimental conditions that can be potentially applied for Larotrectinib scale-up with good product purity and yield.
科研通智能强力驱动
Strongly Powered by AbleSci AI